Biomea Fusion, Inc.

NASDAQ (USD): Biomea Fusion, Inc. (BMEA)

Last Price

9.90

Today's Change

+0.33 (3.44%)

Day's Change

9.70 - 12.00

Trading Volume

4,031,910

Overview

Market Cap

358 Million

Shares Outstanding

36 Million

Avg Volume

736,858

Avg Price (50 Days)

6.75

Avg Price (200 Days)

11.20

PE Ratio

-2.54

EPS

-3.90

Earnings Announcement

29-Oct-2024

Previous Close

9.57

Open

11.48

Day's Range

9.7 - 12.0091

Year Range

3.61 - 22.74

Trading Volume

4,031,910

Price Change Highlight

1 Day Change

3.45%

5 Day Change

13.01%

1 Month Change

31.30%

3 Month Change

120.00%

6 Month Change

-33.78%

Ytd Change

-32.52%

1 Year Change

-26.34%

3 Year Change

-9.17%

5 Year Change

-41.76%

10 Year Change

-41.76%

Max Change

-41.76%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment